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Cerium oxide nanoparticles attenuate
acute kidney injury induced by intra‑abdominal
infection in Sprague–Dawley rats
Nandini D. P. K. Manne1,2,3, Ravikumar Arvapalli1, Niraj Nepal1,4, Tolou Shokuhfar5, Kevin M. Rice1,
Shinichi Asano1 and Eric R. Blough1,3,4*

Abstract
Background: Intra-abdominal infection or peritonitis is a cause for great concern due to high mortality rates. The
prognosis of severe intra-abdominal infection is significantly diminished in the presence of acute kidney injury (AKI)
which is often characterized by renal tubular cell death that can lead to renal failure. The purpose of the current study
is to examine the therapeutic efficacy of cerium oxide (CeO2) nanoparticles for the treatment of peritonitis-induced
AKI by polymicrobial insult.
Results: A one-time administration of CeO2 nanoparticles (0.5 mg/kg) in the absence of antibiotics or other supportive care, attenuated peritonitis-induced tubular dilatation and the loss of brush border in male Sprague–Dawley
rats. These improvements in renal structure were accompanied by decreases in serum cystatin-C levels, reduced renal
oxidative stress, diminished Stat-3 phosphorylation and an attenuation of caspase-3 cleavage suggesting that the
nanoparticle treatment improved renal glomerular filtration rate, diminished renal inflammation and reduced renal
apoptosis. Consistent with these data, further analysis demonstrated that the CeO2 nanoparticle treatment diminished peritonitis-induced increases in serum kidney injury molecule-1 (KIM-1), osteopontin, β-2 microglobulin and
vascular endothelial growth factor-A (VEGF-A) levels. In addition, the nanoparticle attenuated peritonitis-induced
hyperglycemia along with increases in blood urea nitrogen (BUN), serum potassium and sodium.
Conclusion: CeO2 nanoparticles scavenge reactive oxygen species and attenuate polymicrobial insult induced
increase in inflammatory mediators and subsequent AKI. Taken together, the data indicate that CeO2 nanoparticles
may be useful as an alternative therapeutic agent or in conjunction with standard medical care for the treatment of
peritonitis induced acute kidney injury.
Keywords: Cerium oxide nanoparticles, Polymicrobial insult, Acute kidney injury, Reactive oxygen species, Peritonitis
Background
Intra-abdominal infection-induced peritonitis is characterized by an overwhelming immune response in reaction to the presence of infectious agents that can lead to
multi-organ failure and death if not properly managed.
Acute kidney injury (AKI) induced by polymicrobial
insult is a cause of great concern as it increases mortality rates and is also associated with increased financial
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burden and length of hospital stay [1]. Despite advances
in medical science and care, sepsis still baffles the
research community due to its complex pathophysiology
and rapid progression making current therapeutic interventions ineffective.
Intra-abdominal infection-induced acute renal failure
is caused by a multitude of factors that includes components of ischemia–reperfusion injury, hypoperfusion,
endothelial dysfunction, coagulation defects, cytokine
storm and apoptosis [2–4]. Most studies to-date point
that the single most cause for intra-abdominal infection induced AKI is the development of the systemic
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inflammatory response syndrome (SIRS) which is mediated by increased oxidative stress [5, 6]. Other studies have shown that intra-abdominal infection causes
injury to renal tubular cells by damaging the endothelium
that leads to increased permeability [7]. These changes
are histologically evident by loss of brush border and
increased tubular dilatation [8]. At the cellular level, it
is presumed that polymicrobial insult causes tubular cell
death by caspase mediated apoptosis [2]. As such therapeutic interventions directed towards elimination of
reactive oxygen species (ROS) may be warranted for the
treatment of AKI.
Recent developments in nanotechnology have given
rise to several promising compounds that can effectively
scavenge ROS [9–11]. Among those, CeO2 nanoparticles have been increasingly used in biomedical field for
the treatment of various pathologies involving oxidative
stress [12, 13] and inflammation [14, 15]. A property that
is unique to CeO2 nanoparticles is the ability to cycle
between Ce+3 (reduced) and Ce+4 (oxidized) states which
allows them to effectively scavenge ROS [16]. Other
studies have shown that CeO2 nanoparticles behave as
a superoxide dismutase [17] and catalase [18] mimetic
depending on the redox state of the particles. Researches
have exploited this property of CeO2 nanoparticles for
the treatment of diabetes [19, 20], cancer [21, 22] and
ischemic stroke [23].
Previously we have shown that CeO2 nanoparticles
inhibit intra-abdominal infection induced liver and heart
dysfunction [24]. Whether CeO2 nanoparticles can be
used to attenuate polymicrobial insult-induced AKI is
not known. In continuation with our previous study, we
evaluated the therapeutic efficacy of CeO2 nanoparticles
for the treatment of polymicrobial insult-induced AKI
by examining the effect of nanoparticle intervention on
renal histological damage, oxidative stress, inflammation,
apoptosis and changes in circulating AKI biomarkers.

Results
Characterization of nanoceria

Scanning transmission electron microscopy (STEM) was
used to demonstrate the ordered structure of nanoparticles while transmission electron microscopy (TEM) demonstrated the size of CeO2 nanoparticles to be in between
10-40 nm (Fig. 1a, b). Energy dispersive X-ray spectroscopy (EDS) indicated that the content of cerium and oxygen in the sample to be 80.38 and 16.26 %, respectively
(Fig. 1c).
Cerium oxide nanoparticles attenuate peritonitis induced
renal damage and breakdown of tubular F‑actin

Polymicrobial insult-induced AKI was characterized by
renal tubular dilatation, loss of brush border and damage
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to the glomerular capillary network (Fig. 2c, g) which
appeared to be attenuated with nanoparticle treatment
(Fig. 2d, h). Renal sections of peritonitis induced animals showed marked loss of F-actin in proximal tubular
cells (Fig. 3c) which was attenuated with nanoparticle
treatment (Fig. 3d). The mean fluorescence intensity for
F-actin was higher in peritonitis +CeO2 group by 61 %
when compared to peritonitis group alone (Fig. 3e)
(P < 0.05).
Cerium oxide nanoparticles attenuate peritonitis induced
oxidative stress, stat‑3 activation, cleavage of caspase 3
and serum biomarkers of renal failure

Compared to control and treated animals, the renal sections obtained from animals suffering from peritonitis
exhibited increased superoxide levels (Fig. 4c, e; P < 0.05).
Similarly, nanoparticle treatment decreased peritonitis
induced increases in the ratio of phosphorylated to total
levels of Stat-3 (Fig. 5a; P < 0.05) and caspase-3 cleavage
(Fig. 5b; P < 0.05) at 18 h. Compared to the control group
and treated animals, peritonitis increased the levels of
β-2 microglobulin at 3 h and 18 h and the levels of KIM1, cystatin-C, osteopontin and VEGF-A at 18 h (Table 1;
P < 0.05).
Cerium oxide nanoparticles attenuate peritonitis induced
changes in serum biochemical parameters

Peritonitis caused a decrease in serum levels of sodium
at 3 h and an increase in levels of potassium at 18 h
(Table 2; P < 0.05). Nanoparticle treatment attenuated
peritonitis-induced changes in serum sodium and potassium (Table 2; P < 0.05). Similarly, peritonitis induced
early hyperglycemia and increases in levels of BUN at 3 h
time point were attenuated with nanoparticles treatment
(Table 2; P < 0.05).

Discussion
Intra-abdominal infection or peritonitis-induced AKI
has a poor prognosis despite recent advances in medical care. Studies have shown that peritonitis-induced
AKI is associated with increases in oxidative and nitrosative stress which promote renal inflammation, tubular dilatation, vacuolization, sloughing of epithelial cells
and loss of brush border which if severe can cause renal
failure [25, 26]. CeO2 nanoparticles have been shown to
act as an anti-oxidant and anti-inflammatory agent in
the treatment of several diseases including cancer and
diabetes [27, 28]. Similarly, previous work by our laboratory has showed that CeO2 nanoparticles can attenuate
intra-abdominal infection-induced animal death along
with liver and heart damage [24]. With this in mind, we
hypothesized that CeO2 nanoparticles could be used to
prevent peritonitis induced AKI.
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Fig. 1 Characterization of CeO2 nanoparticles. a Scanning transmission electron microscopy (STEM), b Transmission electron microscopy (TEM),
c Energy-Dispersive X-Ray Spectroscopy (EDS)

Fig. 2 CeO2 nanoparticles attenuate peritonitis induced renal damage. Hematoxylin and eosin staining of kidney sections 18 h after polymicrobial
insult. a Control, b CeO2, c Peritonitis, d Peritonitis + CeO2 (200× magnification), e Control, f CeO2, g Peritonitis, h Peritonitis + CeO2 (400× magnification) (n = 4/group)
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Fig. 3 CeO2 nanoparticles attenuate peritonitis induced loss of
F-actin. Rhodamine phalloidin staining of F-actin of kidney sections 18 h after polymicrobial insult. a Control, b CeO2, c Peritonitis, d
Peritonitis + CeO2 and e Relative fluorescence intensity as a measure
of F-actin levels. 200× magnification. *P < 0.05 compared to control
group, $P < 0.05 compared to CeO2 group and #P < 0.05 compared to
peritonitis group (n = 3/group)

Previous studies have shown that peritonitis induced
by polymicrobial insult leads to marked tubular damage
along with loss of brush border and derangement in glomerular capillary network [29]. We found that the CeO2
nanoparticle treatment attenuated peritonitis-induced
damage to the renal glomeruli and tubules (Fig. 1). AKI is
characterized by the loss of F-actin that leads to disruption in cytoskeleton network and impairs renal structural
and functional integrity [30]. To address this possibility,
we next sought to determine whether the nanoparticles
can prevent peritonitis-induced changes in renal structural integrity. As expected we found that peritonitis
caused a significant decrease F-actin associated fluorescence which appeared to be attenuated with CeO2 nanoparticle treatment (Fig. 3). Taken together, these data
suggest that the nanoparticle treatment was associated
with diminished AKI.
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Fig. 4 CeO2 nanoparticles attenuate peritonitis induced increase in
renal superoxide levels. Dihydroethidium staining of kidney sections
at 18 h after polymicrobial insult. a Control, b CeO2, c Peritonitis, d
Peritonitis + CeO2 and e Quantification of superoxide levels in different groups. 200× magnification. *P < 0.05 compared to control
group, $P < 0.05 compared to CeO2 group and #P < 0.05 compared to
peritonitis group (n = 4/group)

It is thought that peritonitis is characterized by
increases in oxidative stress which can result in an uncontrolled systemic inflammatory response and multi-organ
failure [31]. Studies have shown that CeO2 nanoparticles are potent ROS scavengers and that they can act as
catalase and SOD mimetics [32]. Supporting these data,
we found that CeO2 nanoparticle treatment significantly
attenuated peritonitis induced-increases in renal superoxide oxide levels (Fig. 4). To extend these findings, we next
examined the phosphorylation (activation) of the inflammatory mediated Jak-Stat proteins [33]. The Jak-Stat
pathway has been shown to participate in the development of diabetic nephropathy, renal fibrosis and ischemia
reperfusion injury where it functions as a key regulator
of cytokine and growth factor signaling [34]. Additional
data has also demonstrated that Stat-3 signaling is necessary for the hypoxia-induced transcription of VEGF [35].
Here we found that peritonitis-induced the activation of
Stat-3 and increased serum VEGF levels. (Fig. 5a; Table 1).
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Fig. 5 CeO2 nanoparticles attenuate peritonitis induced renal inflammation and apoptosis. a Levels of phosphorylated to total Stat-3. b Relative
levels of cleaved caspase-3 and c Relative levels of caspase-3 as determined by immunoblotting. *P < 0.05 compared to control group, $P < 0.05
compared to CeO2 group and #P < 0.05 compared to peritonitis group (n = 5–6/group)

Similarly, a growing body of evidence suggests that the
apoptosis of renal tubular cells is one of the major causes
for AKI in peritonitis induced by polymicrobial insult [36].
Other work has demonstrated that the cleavage of caspase-3 activates gelsolin which has F-actin severing properties [37]. The loss of F-actin in turn, causes cytoskeletal
derangement that can result in apoptotic cell death [30].
In agreement with our fluorescent measurement of actin
levels, we found that peritonitis induced-cleavage of caspase-3 was significantly attenuated by CeO2 nanoparticle treatment (Figs. 3, 5a). Taken together and consistent
with our histological findings of diminished renal damage,
these data suggest that nanoparticle treatment is associated with decreased renal superoxide levels, reduced renal
inflammation, and diminished renal apoptosis.

In addition to changes in cellular structure, AKI has
also been shown to be associated with decreases in glomerular filtration rate and alterations in serum KIM-1,
β-2 microglobulin, and osteopontin levels [38–40]. As
expected, peritonitis was associated with alterations in
the serum level of all of these variables which appeared
to be significantly diminished with nanoparticle treatment (Table 1). In a similar fashion, hyponatremia,
hyperkalemia, hyperglycemia, and increased blood urea
nitrogen levels are generally found in acute renal failure
with decreased renal tubular flow rate [8, 41]. Consistent with these findings, we found similar changes in the
present study, and importantly, demonstrated a reduction in these variables with nanoparticle treatment
(Table 2).

Below LLOQ

11.00 ± 0.58
Below LLOQ

11.00 ± 0.58

Below LLOQ
Below LLOQ

12.33 ± 0.33

Below LLOQ

690.33 ± 42.10

77.33 ± 1.76*$

76.00 ± 1.53*$
686.00 ± 14.47

Peritonitis +
CeO2 3 h

Peritonitis 3 h

Below LLOQ

9.70 ± 0.00

Below LLOQ

699.67 ± 52.67

52.00 ± 3.51

Sham control 18 h

*P < 0.05 compared to control group, $P < 0.05 compared to CeO2 group and #P < 0.05 compared to peritonitis group (n = 6/group)

LLOQ lower limit of quantitation

Below LLOQ

10.80 ± 1.20

Osteopontin (ng/mL)

VEGF-A (pg/mL)

Below LLOQ

KIM-1 (ng/mL)

Below LLOQ

633.00 ± 30.57

578.67 ± 14.25

Cystatin-C (ng/mL)

CeO2 3 h
49.67 ± 2.40

Sham
control 3 h

β2-Microglobulin (µg/ 54.00 ± 3.00
mL)

Analyte

Table 1 CeO2 nanoparticles attenuate peritonitis induced increase in biomarkers of AKI

Below LLOQ

7.93 ± 0.23*

Below LLOQ

555.33 ± 41.63

32.67 ± 1.45*

CeO2 18 h

459.00 ± 12.70

72.33 ± 4.84

*$

296.67 ± 31.33#

36.33 ± 1.76*$#

2.50 ± 0.10#

1093.33 ± 37.56*$#

1890.00 ± 62.45*$
3.27 ± 0.13

78.33 ± 7.21*$#

Peritoni‑
tis + CeO2 18 h
128.00 ± 5.85*$

Peritonitis 18 h
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5.91 ± 0.37

5.44 ± 0.11

142.86 ± 0.88

140.14 ± 0.51#

136.75 ± 1.36*$
6.36 ± 0.27

6.30 ± 0.23

24.71 ± 1.17#

308.57 ± 22.58#

426.88 ± 19.74*$
29.88 ± 1.97*$

Peritonitis + CeO2
3h

Peritonitis 3 h

5.62 ± 0.24

142.00 ± 1.21

19.17 ± 0.54

245.33 ± 13.25

Sham control 18 h

*P < 0.05 compared to control group, $P < 0.05 compared to CeO2 group and #P < 0.05 compared to peritonitis group (n = 6/group)

Potassium (mmol/L)

142.43 ± 0.72

Sodium (mmol/L)

21.00 ± 1.00

262.29 ± 10.13

284.00 ± 8.11

22.00 ± 1.10

CeO2 3 h

Sham control 3 h

Blood urea nitrogen
(mg/dL)

Glucose (mg/dL)

Analyte

Table 2 CeO2 nanoparticles attenuate peritonitis insult induced alterations in serum biochemical parameters

5.75 ± 0.33

141.63 ± 0.91

18.50 ± 0.89

290.63 ± 17.16*

CeO2 18 h

7.83 ± 0.24*$

138.80 ± 0.84

71.30 ± 7.20*$

105.50 ± 8.53*$

Peritonitis 18 h

7.06 ± 0.21*$#

140.63 ± 0.50

57.37 ± 3.09$

125.25 ± 5.06*$

Peritoni‑
tis + CeO2
18 h
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Conclusion
The results of the current study suggest that a single,
“stand-alone” dose of CeO2 nanoparticles confers protection against severe polymicrobial insult-induced acute
kidney injury. Our data suggest that the CeO2 nanoparticles act by scavenging reactive oxygen species which is
associated with diminished caspase-3 activation, reduced
loss of F-actin and less damage to the tubules. Improvements in kidney structure were accompanied by evidence of increased renal function and decreased serum
biomarker levels of renal injury (Fig. 6). Taken together,
these data suggest that further investigation into the
potential utility of using CeO2 nanoparticles for the treatment of polymicrobial-induced AKI may be warranted.
Methods
Characterization of CeO2 nanoparticles

CeO2 nanoparticles were commercially purchased from
US Research Nanomaterials Inc. (Houston, TX, USA).
Scanning transmission electron microscopy (STEM)
images were obtained by using Aberration Corrected
Analytical Electron Microscope (TEM/STEM JEOL
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JEM-ARM200CF, Japan) operated at 200 keV. Particle
size was obtained using JEOL JEM-2010 transmission
electron microscope (TEM). Sample purity was estimated by energy dispersive X-ray spectroscopy using
Noran Voyager EDX software.
Polymicrobial insult and CeO2 nanoparticle treatment

Male Sprague–Dawley rats aged 10 weeks were purchased from Hill-Top laboratories and allowed to
acclimatize for 2 weeks prior to experimentation. All surgical procedures were performed in accordance with the
guidelines provided by Marshall University Institutional
Animal Care and Use Committee (IACUC), and Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC). Briefly, animals were anesthetized under isoflurane and a small mid ventral incision of
0.5 cm was made. Sham controls and CeO2 only groups
were injected with 5 ml/kg of 5 % sterile dextrose solution intra-peritoneally (i.p) while peritonitis and peritonitis +CeO2 groups received cecal inoculum of 600 mg/
kg BW in 5 ml/kg BW of 5 % sterile dextrose solution i.p
as described previously [42]. Cecal material was obtained

Fig. 6 Schematic representation of mechanism of action of CeO2 nanoparticles on polymicrobial insult induced AKI

Manne et al. J Nanobiotechnol (2015) 13:75

from healthy donor rats. The sham control and peritonitis groups were injected with 200 µl of sterile distilled
water intravenously while the CeO2 and peritonitis
+CeO2 groups received CeO2 nanoparticles (0.5 mg/kg)
in 200 µl of sterile distilled water via tail vein injection.
Tissue collection

Animals were humanely sacrificed under anesthesia and
the kidneys were excised, capsule removed and washed
in Krebs–Ringer bicarbonate buffer (KRB) to remove any
blood. Kidneys were frozen in liquid nitrogen and stored
at −80 °C until further analysis. Serum was obtained
from whole blood by centrifugation at 5000×g for 10 min
at room temperature and stored at −80 °C.
Renal histology and staining for F‑actin

Frozen kidneys were sectioned (4 µm) with a Leica CM1950
cryostat and transferred to poly-l-lysine coated slides.
Hematoxylin and eosin staining was performed using Histoperfect kit (BBC Biochemical, Seattle WA, USA) to assess
kidney morphology and imaged using Evos XL microscope
(Life Technologies, Grand Island, NY, USA).
Renal sections were stained for F-actin using rhodamine phalloidin (Life technologies, Grand Island, NY,
USA). Briefly, frozen sections were washed with PBS and
fixed in 4 % methanol free formaldehyde for 10 min and
washed with PBS (3 × 5 min). Sections were then permeabilized with 0.3 % Triton X-100 in PBS for 20 min and
washed with PBS (3 × 5 min). After blocking with 1 %
BSA for 30 min, the tissue sections were incubated with
0.165 µM rhodamine phalloidin for 20 min in the dark,
washed with PBS (3 × 5 min), cover slipped and then
imaged with a Evos FL microscope (Life Technologies,
Grand Island, NY, USA). Four images per section from at
least three different animals from each group were evaluated for fluorescence intensity using Image J analysis
software.
Estimation of renal superoxide levels

Superoxide levels in renal sections were estimated using
dihydroethidium staining as described previously [43].
Briefly, sections were washed with PBS and incubated
with 5 mM dihydroethidium for 1 h at room temperature
in the dark. After washing with PBS (3 × 5 min), sections
were imaged with an Evos FL microscope (Life Technologies, Grand Island, NY, USA). Four images per section
from at least four different animals from each group were
evaluated for fluorescence intensity using Image J analysis software.
SDS‑PAGE and immunoblotting

Approximately 100 mg of frozen kidney was taken and
pulverized to a fine powder, suspended in 900 µl of T-PER
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(Pierce, Rockford, IL, USA) containing 1 % protease and
phosphatase inhibitors and homogenized. Supernants
were collected by centrifugation (10,000×g for 10 min
at 4 °C and the protein concentration determined using
the 660 nm assay (Pierce, Rockford, IL, USA). Samples
were equally diluted with 4× Laemilli buffer and then
subjected to electrophoresis on 10 % PAGEr Gold Precast
gel (Lonza, Rockland, ME, USA) before transfer to nitrocellulose membranes as detailed elsewhere [44]. Equal
loading of protein was verified by Ponceau S staining of
nitrocellulose membranes. Membranes were blocked
with 5 % milk in TBST for 1 h and later probed with primary antibodies against p-stat-3 (Tyr 705), stat-3, cleaved
caspase-3 and caspase-3 (Cell Signaling Technology,
Danvers, MA, USA). After exposure to the primary antibodies, membranes were washed with TBST (3 × 5 min)
and incubated with secondary anti-rabbit (Cell Signaling
Technology, Danvers, MA, USA) for 1 h at room temperature. Immunoreactivity was visualized using Supersignal
West Pico Chemiluminiscent substrate (Pierce, Rockford,
IL, USA) and quantified by Fluorchem 9900 software
(Protein Simple, Santa Clara, CA, USA).
Multiplex immunoassay and serum biochemical analysis

Serum samples from different animals in each group
were pooled and sent to Myriad RBM (Austin, TX, USA)
for the analysis of KIM-1, cystatin-C, osteopontin, β-2
microglobulin and VEGF-A using the rodent kidney
MAP. Samples were run in triplicate for statistical analysis. The amount of glucose, BUN, sodium and potassium
were determined in serum using an Abaxis VetScan®
analyzer (Abaxis, Union City, CA, USA).
Statistical analysis

Results are presented in the form of mean ± standard error of mean. Differences in dependent variables
across groups were determined by one way analysis of
variance (ANOVA) with Student Newman Keul’s post
hoc analysis or ANOVA on ranks with Student Newman Keul’s post hoc analysis for non-normally distributed samples. Where appropriate a t test was used. A
probability value of P < 0.05 was accepted to be statistically significant.
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